Afghanistan vs Congo: Previously treated cases tested for RR-/MDR-TB
Afghanistan
100.0%
in 2024
Congo
100.0%
in 2024
Afghanistan rank
1st
Congo rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Afghanistan
- Congo
How they compare
Afghanistan currently reports 100.0% against 100.0% in Congo, a difference of 0.0%.
The two have swapped places 5 times across 10 shared years of data; in 2013 it was Afghanistan ahead.
Afghanistan ranks 1st and Congo ranks 1st of 180 countries.
Across the 2 decades both report, Afghanistan averaged higher in 1 and Congo in 1.
Head to head by decade
| Decade | Afghanistan | Congo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 43.6% | 77.2% | 33.6% | Congo |
| 2020s | 89.0% | 62.2% | 26.8% | Afghanistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Afghanistan or Congo?
- Afghanistan, at 100.0% against 100.0% in Congo as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Afghanistan and Congo?
- 0.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Congo?
- 10 years are reported by both, from 2013 to 2024.
- How do Afghanistan and Congo rank globally for previously treated cases tested for rr-/mdr-tb?
- Afghanistan ranks 1st and Congo ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.